175 related articles for article (PubMed ID: 2543771)
21. Type 2 poliovirus recombinants isolated from vaccine-associated cases and from healthy contacts in Brazil.
Friedrich F; Da-Silva EF; Schatzmayr HG
Acta Virol; 1996 Feb; 40(1):27-33. PubMed ID: 8886095
[TBL] [Abstract][Full Text] [Related]
22. Genetic stability and mutant selection in Sabin 2 strain of oral poliovirus vaccine grown under different cell culture conditions.
Taffs RE; Chumakov KM; Rezapkin GV; Lu Z; Douthitt M; Dragunsky EM; Levenbook IS
Virology; 1995 Jun; 209(2):366-73. PubMed ID: 7778271
[TBL] [Abstract][Full Text] [Related]
23. An infectious cDNA clone of the poliovirus Sabin strain could be used as a stable repository and inoculum for the oral polio live vaccine.
Kohara M; Abe S; Kuge S; Semler BL; Komatsu T; Arita M; Itoh H; Nomoto A
Virology; 1986 May; 151(1):21-30. PubMed ID: 3008430
[TBL] [Abstract][Full Text] [Related]
24. Retrospective molecular and phenotypic analysis of poliovirus vaccine strains isolated in Greece.
Pliaka V; Filliponi ME; Kyriakopoulou Z; Ruether IG; Tsakogiannis D; Gartzonika C; Levidiotou-Stefanou S; Markoulatos P
Clin Microbiol Infect; 2011 Oct; 17(10):1554-62. PubMed ID: 21375661
[TBL] [Abstract][Full Text] [Related]
25. Mapping of mutations contributing to the temperature sensitivity of the Sabin 1 vaccine strain of poliovirus.
Georgescu MM; Tardy-Panit M; Guillot S; Crainic R; Delpeyroux F
J Virol; 1995 Sep; 69(9):5278-86. PubMed ID: 7636970
[TBL] [Abstract][Full Text] [Related]
26. Modulation of poliovirus replicative fitness in HeLa cells by deoptimization of synonymous codon usage in the capsid region.
Burns CC; Shaw J; Campagnoli R; Jorba J; Vincent A; Quay J; Kew O
J Virol; 2006 Apr; 80(7):3259-72. PubMed ID: 16537593
[TBL] [Abstract][Full Text] [Related]
27. Determinants in the 5' noncoding region of poliovirus Sabin 1 RNA that influence the attenuation phenotype.
Kawamura N; Kohara M; Abe S; Komatsu T; Tago K; Arita M; Nomoto A
J Virol; 1989 Mar; 63(3):1302-9. PubMed ID: 2536835
[TBL] [Abstract][Full Text] [Related]
28. The molecular biology of poliovaccines.
Minor PD
J Gen Virol; 1992 Dec; 73 ( Pt 12)():3065-77. PubMed ID: 1335021
[No Abstract] [Full Text] [Related]
29. Studies on the attenuation of the Sabin type 3 oral polio vaccine.
Almond JW; Westrop GD; Evans DM; Dunn G; Minor PD; Magrath D; Schild GC
J Virol Methods; 1987 Aug; 17(1-2):183-9. PubMed ID: 2822753
[TBL] [Abstract][Full Text] [Related]
30. Clustered charged-to-alanine mutagenesis of poliovirus RNA-dependent RNA polymerase yields multiple temperature-sensitive mutants defective in RNA synthesis.
Diamond SE; Kirkegaard K
J Virol; 1994 Feb; 68(2):863-76. PubMed ID: 8289389
[TBL] [Abstract][Full Text] [Related]
31. Conditional poliovirus mutants made by random deletion mutagenesis of infectious cDNA.
Kirkegaard K; Nelsen B
J Virol; 1990 Jan; 64(1):185-94. PubMed ID: 2152811
[TBL] [Abstract][Full Text] [Related]
32. Cold-adapted poliovirus mutants bypass a postentry replication block.
Dove AW; Racaniello VR
J Virol; 1997 Jun; 71(6):4728-35. PubMed ID: 9151866
[TBL] [Abstract][Full Text] [Related]
33. A C-terminal, cysteine-rich site in poliovirus 2C(ATPase) is required for morphogenesis.
Wang C; Ma HC; Wimmer E; Jiang P; Paul AV
J Gen Virol; 2014 Jun; 95(Pt 6):1255-1265. PubMed ID: 24558221
[TBL] [Abstract][Full Text] [Related]
34. Complete nucleotide sequence of the attenuated poliovirus Sabin 1 strain genome.
Nomoto A; Omata T; Toyoda H; Kuge S; Horie H; Kataoka Y; Genba Y; Nakano Y; Imura N
Proc Natl Acad Sci U S A; 1982 Oct; 79(19):5793-7. PubMed ID: 6310545
[TBL] [Abstract][Full Text] [Related]
35. Alanine scanning of poliovirus 2CATPase reveals new genetic evidence that capsid protein/2CATPase interactions are essential for morphogenesis.
Wang C; Jiang P; Sand C; Paul AV; Wimmer E
J Virol; 2012 Sep; 86(18):9964-75. PubMed ID: 22761387
[TBL] [Abstract][Full Text] [Related]
36. Localization of genomic regions specific for the attenuated, mouse-adapted poliovirus type 2 strain W-2.
Pevear DC; Oh CK; Cunningham LL; Calenoff M; Jubelt B
J Gen Virol; 1990 Jan; 71 ( Pt 1)():43-52. PubMed ID: 2154539
[TBL] [Abstract][Full Text] [Related]
37. Mapping of mutations associated with neurovirulence in monkeys infected with Sabin 1 poliovirus revertants selected at high temperature.
Christodoulou C; Colbere-Garapin F; Macadam A; Taffs LF; Marsden S; Minor P; Horaud F
J Virol; 1990 Oct; 64(10):4922-9. PubMed ID: 2168976
[TBL] [Abstract][Full Text] [Related]
38. Determination of antigenic properties of vaccine derived poliovirus strains.
Pliaka V; Achilleos C; Kyriakopoulou Z; Tsakogiannis D; Ruether IG; Gartzonica C; Levidiotou-Stefanou S; Markoulatos P
Vaccine; 2010 Dec; 29(1):26-33. PubMed ID: 20974307
[TBL] [Abstract][Full Text] [Related]
39. Construction of viable deletion and insertion mutants of the Sabin strain of type 1 poliovirus: function of the 5' noncoding sequence in viral replication.
Kuge S; Nomoto A
J Virol; 1987 May; 61(5):1478-87. PubMed ID: 3033275
[TBL] [Abstract][Full Text] [Related]
40. Nucleic acid sequence of the region of the genome encoding capsid protein VP1 of neurovirulent and attenuated type 3 polioviruses.
Stanway G; Cann AJ; Hauptmann R; Mountford RC; Clarke LD; Reeve P; Minor PD; Schild GC; Almond JW
Eur J Biochem; 1983 Oct; 135(3):529-33. PubMed ID: 6311539
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]